Skip to content
Governance Register

← US public companies

Intrabiotics Pharmaceuticals INC /DE

SEC CIK 1103390 · RDEA · last insider filing 2012-06-21

Directors (from insider filings)

NameCapacity as filedFilings
Baker Julian Director filed 2006 - 2012
Baker Felix Director filed 2006 - 2012
Baker Bros. Advisors LP Director filed 2012 - 2012
Tang Kevin C Director filed 2006 - 2012
Fuchs Henry J Director filed 2006 - 2012
Dixon Wendy L Director filed 2011 - 2012
Poyhonen John Director filed 2007 - 2012
Beck John W Director · SVP, Finance & Operations, CFO filed 2007 - 2012
Johnson Craig A Director filed 2008 - 2012
Quart Barry D Director · President, CEO and Secretary filed 2006 - 2012
Baker Brothers Life Sciences Capital (GP), LLC Director filed 2006 - 2012
14159 Capital (GP), LLC Director filed 2006 - 2012
Baker Bros. Capital (GP), LLC Director filed 2006 - 2011
Remington Jack Director filed 2006 - 2011

Officers (from insider filings)

NameTitle as filedFilings
Davis Stephen EVP & COO filed 2010 - 2012
Manhard Kimberly Sr. VP, Reg Affairs & Ops filed 2006 - 2012
Hagerty David T Senior VP & CMO filed 2011 - 2012
Krueger Christopher W Sr. VP, Chief Business Officer filed 2007 - 2010
Hickey Denis Chief Financial Officer filed 2006 - 2007
O'Connor Patrick M Sr. VP, R & Pre-Clin.Dev., CSO filed 2007 - 2007
Hong Zhi Executive VP. Research filed 2006 - 2006

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.